Media Room
Third quarter 2024 results
Third quarter 2024 results will be reviewed by management during a live audio webcast with the financial community. The presentation will be followed by a Q&A session.
Friday October 25, 2024
14:00 - 15:30 CET (8:00am – 9:30am EST)
Press releases
September 27, 2024
Press Release: Dupixent approved in the US as the first-ever biologic medicine for patients with COPD
September 27, 2024
Press Release: Dupixent approved in China as the first-ever biologic medicine for patients with COPD
Contact Our Media Team
You are a journalist and have a question about Sanofi, please contact the Global Media relations team. Please note the contact details are only for journalists.
Publications
Half Year 2024 Financial Report XBRL Package
Half Year 2024 Financial Report
Declaration of extra-financial performance 2023 (ESG Report)
Half Year 2023 Financial Report